Pharma Media in 2026: from AI hype to accountable execution

Solli’s take on the PulsePoint x CMI Media Group trends report shares that 2026 marks a pivotal year for pharma marketers, emphasizing a shift from AI experimentation to demonstrable value and accountable execution. With growing pressure for data transparency and interoperability, the industry will focus on translating digital spend into measurable outcomes, particularly through the convergence of HCP and DTC strategies, which are increasingly personalized and performance-driven across digital channels.